HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.

Hunger, S P; Tkachuk, D C; Amylon, M D; Link, M P; Carroll, A J; Welborn, J L; Willman, C L; Cleary, M L

Hunger, S P; Tkachuk, D C; Amylon, M D; Link, M P; Carroll, A J; Welborn, J L; Willman, C L; Cleary, M L.

Affiliation

Hunger SP; Department of Pathology, Stanford University School of Medicine 94305-5324.

Blood ; 81(12): 3197-203, 1993 Jun 15.

Article in En | MEDLINE | ID: mdl-8389614

Subject(s)

Chromosome Aberrations; Chromosomes, Human, Pair 11; Leukemia/genetics; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Blotting, Southern; Child; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute/chemically induced; Leukemia, Myeloid, Acute/genetics; Leukemia-Lymphoma, Adult T-Cell/genetics; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma/chemically induced; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics; Topoisomerase II Inhibitors; Translocation, Genetic

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 11 / Leukemia / Chromosome Aberrations Limits: Child / Humans / Male Language: En Journal: Blood Year: 1993 Type: Article

Search on Google

XML

PubMed Links